Hospital

Fuwai Hospital中国医学科学院阜外医院

Beijing 北京市University-affiliated (from the hospital's own published name)In 1 published list

Ask about this hospital Send us a message See all hospitals in Beijing

At a glance

Published values only, each read from the record this page is built on. The listings behind them are in the section below.

Fudan University hospital rankings A+++ General list, 2023
Published research 19 PubMed records we hold for this hospital (the newest twenty per hospital)
Registered studies 5 records we hold for this hospital, as registered

Rankings & accreditation

These listings are published by the bodies that run them, not by this site. Every line carries the year it was published and a link to its source; this is not a paid or promoted listing.

Fudan University hospital rankings

Item	Rank / tier	Year	Caliber	Source
General list	A+++	2023	Tier only; hospitals in the same tier are not ordered against each other	https://rank.cn-healthcare.com/fudan/national-general

See the full list of rankings and platforms →

For international patients

A line appears here only where we hold a record for it. A line that is missing has not been verified - ask us and we will put the question to the hospital.

Hospital details

Chinese name: 中国医学科学院阜外医院
English name: Fuwai Hospital

Values written in Chinese are quoted as published by the source.

The grade list reference is the date or review batch the official list was published under; it is quoted in the source's language.

Also known as

Fu Wai Hospital

Evidence for this condition

Selected using official public data sources

Colorectal cancer

Beijing 北京市
Published research
- Lipopolysaccharide-binding proteins and vasodilator-stimulated phosphoproteins as novel screening biomarkers for advanced adenoma and colorectal cancer. Discover oncology, 2026
- Chlorogenic acid promotes macrophage phagocytosis through the METTL3-SIRPA axis in an m6A-dependent manner for colon cancer therapy. Biochemical pharmacology, 2026
1 more published study

PubMed indexes 3 papers on this condition that name this hospital.
Breast cancer

Beijing 北京市
Published research
- Small extracellular vesicles orchestrated pathological communications between breast cancer cells and cardiomyocytes as a novel mechanism exacerbating anthracycline cardiotoxicity by fueling ferroptosis. Redox biology, 2025
PubMed indexes 1 paper on this condition that names this hospital.
Lung cancer

Beijing 北京市
Published research
- CYBB identified as a key immune hub gene linking lung cancer and atrial fibrillation. Journal of cardiothoracic surgery, 2025
- Role of statins in non-small cell lung cancer treatment: a systematic review and meta-analysis. BMJ open, 2025
4 more published studies

PubMed indexes 6 papers on this condition that name this hospital.
Liver cancer

Beijing 北京市
Published research
- The liver cancer due to non-alcoholic steatohepatitis attributable to metabolic risk factors in 204 countries and territories, 1990-2021: an age-period-cohort analysis from the Global Burden of Disease study. International journal of surgery (London, England), 2026
- Bioengineered Exosome-Magnetic Nanoplatform for Precision Therapy of Hepatocellular Carcinoma via Dual-Targeted Drug Delivery. International journal of nanomedicine, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Stomach cancer

Beijing 北京市
Published research
- Advanced therapies for stomach cancer. Journal of investigative medicine : the official publication of the American Federation for Clinical Research, 2025
- Ditrioxzin synergizes with 2-deoxy-d-glucose to induce redox-dependent metabolic crisis in gastric cancer through dual targeting of peroxiredoxin 3 and glycolysis. Toxicology and applied pharmacology, 2026
1 more published study

PubMed indexes 3 papers on this condition that name this hospital.
Prostate cancer

Beijing 北京市
Published research
- Prospective cohort study integrating plasma proteomics and machine learning for early risk prediction of prostate cancer. International journal of surgery (London, England), 2025
- Discovery of Novel CBP/p300 and BRD4 Dual-Target PROTACs with Potent Antitumor Activity in Prostate Cancer. Journal of medicinal chemistry, 2026
PubMed indexes 2 papers on this condition that name this hospital.
Esophageal cancer

Beijing 北京市
Published research
- STIP1 drives Metabolic Reprogramming in Esophageal Squamous Cell Carcinoma via AHCY-LDHA Axis. Exploration (Beijing, China), 2025
- USP5 regulates purine metabolism and represents a therapeutic target in esophageal cancer. Cell death & disease, 2026
PubMed indexes 2 papers on this condition that name this hospital.

Other hospitals in Beijing

See all hospitals in Beijing →

Source & evidence

Source URL: https://rank.cn-healthcare.com/fudan/national-general
Source scheme: https
Source type: Third-party compilation
Evidence level: B - hospital self-statement or authoritative media
Retrieved on: 2026-09-24